Title: Pharmacologic Characterization of Valbenazine (NBI-98854) and Its Metabolites.
Journal: The Journal of pharmacology and experimental therapeutics 20170601
Title: NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study.
Journal: Movement disorders : official journal of the Movement Disorder Society 20151001
Title: Dimitri E Grigoriadis, et al. Pharmacologic Characterization of Valbenazine (NBI-98854) and Its Metabolites. J Pharmacol Exp Ther. 2017 Jun;361(3):454-461.